共 50 条
- [41] Risk of viral reactivation in patients with occult hepatitis B virus infection during ruxolitinib treatment Annals of Hematology, 2019, 98 : 215 - 218
- [43] Control of occult hepatitis B virus infection ADVANCES IN LABORATORY MEDICINE-AVANCES EN MEDICINA DE LABORATORIO, 2022, 3 (04): : 321 - 330
- [45] Hepatitis B virus reactivation sustained by a hepatitis B virus surface antigen immune-escape mutant isolate in a patient who was hepatitis B core antibody positive during treatment with sofosbuvir and velpatasvir for hepatitis C virus infection: a case report Journal of Medical Case Reports, 13
- [46] Hepatitis B virus reactivation sustained by a hepatitis B virus surface antigen immune-escape mutant isolate in a patient who was hepatitis B core antibody positive during treatment with sofosbuvir and velpatasvir for hepatitis C virus infection: a case report JOURNAL OF MEDICAL CASE REPORTS, 2019, 13 (01)